APA (7e ed.) Bronvermelding

Leng, Y., Fu, X., Qian, L., Li, Q., Gao, H., Xie, H., & Xie, C. (2022). Efficacy, safety and therapeutic mechanism of Shen-Qi Xiao-Tan formula in the treatment of peripheral atherosclerosis in patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled trial protocol. BMC.

Chicago (17e ed.) Bronvermelding

Leng, Yulin, Xiaoxu Fu, Lisen Qian, Qiqi Li, Hong Gao, Hongyan Xie, en Chunguang Xie. Efficacy, Safety and Therapeutic Mechanism of Shen-Qi Xiao-Tan Formula in the Treatment of Peripheral Atherosclerosis in Patients with Type 2 Diabetes Mellitus: A Randomized, Double-blind, Placebo-controlled Trial Protocol. BMC, 2022.

MLA (9e ed.) Bronvermelding

Leng, Yulin, et al. Efficacy, Safety and Therapeutic Mechanism of Shen-Qi Xiao-Tan Formula in the Treatment of Peripheral Atherosclerosis in Patients with Type 2 Diabetes Mellitus: A Randomized, Double-blind, Placebo-controlled Trial Protocol. BMC, 2022.